CURX vs DVN · $8.9M cap vs P/E 7.4, rev $7.42B
Curanex Pharmaceuticals Inc Common Stock (CURX) versus Devon Energy Corporation (DVN) — a side-by-side from cached financials, not a winner call.
Curanex Pharmaceuticals Inc Common Stock (CURX) is a biotechnology company listed on NASDAQ.
Devon Energy Corporation (DVN) is a oil & gas e&p company listed on US.
CURX does not have a complete income-statement cache yet.
Latest reported DVN revenue for 2026-06-30 was $7.42B. Net income was $1.91B. Revenue was up 94.8% from 2026-03-31 to 2026-06-30. DVN currently screens at market cap $22.42B and trailing P/E 7.4.
CURX currently screens at market cap $8.9M. DVN currently screens at market cap $22.42B and trailing P/E 7.4.
Not investment advice. Open the CURX and DVN stock pages for the full models.
Not investment advice.